| |
| |
|
| Insider
Information: |
Warren Eric |
| Relationship: |
Chief Commercial Officer |
| City: |
Ann Arbor |
| State: |
MI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
168,318 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$334,953 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
168,318 |
|
|
| Total
Value |
$334,953 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Esperion Therapeutics, Inc. |
ESPR |
Chief Commercial Officer |
2024-03-14 |
168,318 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
168,318 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2023-09-20 |
4 |
S |
$1.25 |
$924 |
D/D |
(742) |
68,318 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2023-08-18 |
4 |
S |
$1.41 |
$344 |
D/D |
(243) |
69,060 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2023-07-19 |
4 |
S |
$1.59 |
$168 |
D/D |
(106) |
69,303 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2023-06-21 |
4 |
S |
$1.48 |
$894 |
D/D |
(603) |
69,409 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2023-05-17 |
4 |
S |
$1.62 |
$356 |
D/D |
(219) |
70,012 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2023-04-19 |
4 |
S |
$1.28 |
$147 |
D/D |
(115) |
70,231 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2023-03-17 |
4 |
S |
$1.78 |
$937 |
D/D |
(526) |
70,346 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2023-03-07 |
4 |
S |
$5.06 |
$25,730 |
D/D |
(5,090) |
48,572 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2022-10-18 |
4 |
S |
$7.69 |
$823 |
D/D |
(107) |
53,662 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2022-09-19 |
4 |
S |
$6.92 |
$1,765 |
D/D |
(255) |
53,769 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2022-08-31 |
4 |
B |
$7.46 |
$7,460 |
D/D |
1,000 |
54,024 |
2.74 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2022-08-17 |
4 |
S |
$6.82 |
$1,356 |
D/D |
(199) |
53,024 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2022-07-19 |
4 |
S |
$6.58 |
$2,837 |
D/D |
(431) |
53,223 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2022-06-17 |
4 |
S |
$4.90 |
$1,254 |
D/D |
(256) |
53,654 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2022-05-17 |
4 |
S |
$5.98 |
$1,172 |
D/D |
(196) |
53,910 |
0 |
% |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial Officer |
• – – |
2022-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
54,106 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
Chief Commercial OfficerOffice |
• – – |
2022-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
41,106 |
|
% |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
